- Home
- Equipment
- north america
- pathology molecular
Show results for
Refine by
Pathology Molecular Equipment Supplied In North America
5 equipment items found
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
The RNAscope 2.5 LS Assay is designed as an automated assay on the Leica Biosystems' BOND RX Research Advanced Staining System. The RNAscope 2.5 LS Assay, is an RNA in situ hybridization assay based on ACD’s patented signal amplification and background suppression technology. The assay uses a novel and proprietary method of in situ hybridization (ISH) to visualize single RNA molecules per ...
by:Clinisys, Inc. based inTucson, ARIZONA (USA)
With Clinisys DaVinci for pathology departments can optimise pathology processes and work more efficiently and collaboratively. It’s a user-friendly, comprehensive solution providing advanced business intelligence and reporting that increases the efficiency of routine tasks and complex workflows, such as anatomical pathology and digital ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. However, within five years, approximately 30% of patients will develop metastasis – rising to nearly 50% in the following ...
Manufactured by:BioGenex Laboratories based inFremont, CALIFORNIA (USA)
Xmatrx® Infinity is a fully automated molecular pathology workstation designed to accelerate life sciences research, drug discovery and development. It is an open system that allows simultaneous optimization of 40 assay parameters in a single run. With 40 individually operable and thermally-cyclable slide blocks, it is feasible to perform any slide-based ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
With the advent of precision medicines that can target unique molecular or genetic features of a patient’s tumor, the field of oncology has a host of alternatives to one-size-fits-all treatments. This is a major advance over traditional chemotherapy, which can be as potent against healthy tissue as it is against cancer. Using tumor genomic profiling and biomarker strategies, physicians can ...